Suchergebnisse - "Zeng, Hui"

PubPharm (32)

1

N,N-dimethylacetamide targets neuroinflammation in Alzheimer's disease in in-vitro and ex-vivo models

enthalten in: Scientific reports | 2023

von Wei, Z. | Koya, J. | Acharekar, N. | +5

2

N,N-Dimethylformamide Delays LPS-Induced Preterm Birth in a Murine Model by Suppressing the Inflammatory Response

enthalten in: Reproductive sciences (Thousand Oaks, Calif.) | 2022

von Wei, Z. | Salami, O. | Koya, J. | +4

3

Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2020

von Brar, S. | Liu, K. | Go, A. | +30

4

LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2

enthalten in: Journal of virology | 2020

von Zhao, X. | Zheng, S. | Chen, D. | +7

5

Cognitive Impairment Among Aging People Living With HIV on Antiretroviral Therapy : A Cross-Sectional Study in Hunan, China

enthalten in: The Journal of the Association of Nurses in AIDS Care : JANAC | 2020

von Xiao, X. | Zeng, H. | Feng, C. | +6

6

A hPSC-based platform to discover gene-environment interactions that impact human β-cell and dopamine neuron survival

enthalten in: Nature communications | 2018

von Zhou, T. | Kim, T. | Chong, C. | +17

7

Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence

enthalten in: Scientific reports | 2016

von Alymova, I. | York, I. | Air, G. | +7

8

Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection

enthalten in: Journal of virology | 2016

von DiPiazza, A. | Richards, K. | Batarse, F. | +5

9

An Isogenic Human ESC Platform for Functional Evaluation of Genome-wide-Association-Study-Identified Diabetes Genes and Drug Discovery

enthalten in: Cell stem cell | 2016

von Zeng, H. | Guo, M. | Zhou, T. | +11

CommentIn: Cell Stem Cell. 2016 Sep 1;19(3):281-2. - PMID 27588741

10

Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL) : Phase II results from Children's Oncology Group (COG) study ADVL04P2

enthalten in: Pediatric blood & cancer | 2015

von Raetz, E. | Cairo, M. | Borowitz, M. | +10